By Andrei Skvarsky.
Moscow-based private equity firm Unicorn has announced it has been hired by a Russian pharmaceutical company to find a strategic investor for it.
Unicorn’s client in the project is Mosfarm, a company headquartered in the Moscow region and one of Russia’s largest manufacturers of infusion solutions.
Unicorn, whose business is focused on Russian small and medium-sized enterprises (SMEs), provides advice on mergers, acquisitions, restructurings, financing and capital structure.
Unicorn’s structure includes buyout funds that invest in controlling stakes in SMEs with the aim of achieving an internal rate of return (IRR) of 25 per cent.
The firm has an office in Vienna in addition to its headquarters in Moscow.
Sorry, comments are closed for this post.